| Revenue Growth | Total revenue $267 million, up 11% YoY; patient management added $17 million. |
|---|---|
| Mgmt Confidence | High confidence in AI-driven productivity and scalability of the Cirrus platform. |
| Demand Visibility | Sales closures more than doubled YoY; three consecutive quarters of sequential increases. |
| Margin Trends | Gross margin expanded from 24% to 27% due to diversified services. |
| Op. Leverage | AI embedding reduces manual activity, allowing adjusters to manage greater claim volumes. |
| Pricing Power | MarketWise Repricing solution strengthens reimbursement management for out-of-network services. |
| Vol vs Price | Volume-led growth with claims volume increasing 11.5% in the September quarter. |
| Segment Growth | Patient management was the largest contributor to revenue growth. |
| New Clients | Launched additional top-ten national health plan; strategic Blue Cross Blue Shield partnership. |
| Capex & Debt | Debt-free balance sheet; $10 million investing activities; $18.1 million share repurchases. |
| Commentary | Strategy focuses on integrating clinical expertise with AI-embedded claims management workflows. |
| New Launches | Launched MyCare portal pilot and MarketWise Repricing; new hospital bill audit offerings. |
Growth
Revenue grew 11% to $267 million; EPS rose $0.13 to $0.67; gross margins expanded to 27%.
Outlook
Focusing on AI-driven operating model changes and expanding the Cirrus payment integrity platform.
Risks
No analyst questions were asked, preventing a stress test of management's claims or projections.
The company's earnings call, NASDAQ: CRVL, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Corvel Corp: key numbers
- Share price
- $87.34Close, Nov 16
- Market cap
- $4.4B
- Shares outstanding
- 50.35MLatest SEC cover page
- Sector
- Finance
- Industry
- Insurance Agents, Brokers & ServiceSIC 6411
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Corvel Corp
All →Corvel Insider Steven J. Hamerslag Sells $924K of Stock
Steven J. Hamerslag sold 11,000 shares of Corvel Corp at $84.04 a share, worth $924K in total on Nov 11, 2026. Shares held after the trade: 276,000 (-3.8%).
- Value
- $924K
- Shares
- 11,000
- Price
- $84.04
- Holding change
- -3.8%
- Trade date
- Nov 11, 2026
Corvel Insider R. Judd Jessup Sells $576K of Stock
R. Judd Jessup sold 6,939 shares of Corvel Corp at $83.01 a share, worth $576K in total on Nov 9, 2026. Shares held after the trade: 104,859 (-6.2%).
- Value
- $576K
- Shares
- 6,939
- Price
- $83.01
- Holding change
- -6.2%
- Trade date
- Nov 9, 2026
Corvel Q2 2026 Results: Net Income $34.1M, Up 22.1% YoY
CorVel Corporation reported a 11.5% increase in quarterly revenue to $267.1 million and a 22.1% increase in net income to $34.1 million for the period ended September 30, 2026. For the first six months of the fiscal year, net income rose to $66.3 million compared to $55.1 million in the prior year, driven by strong gross profit growth.
- Key figure
- Net income $34.1M · +22.1% YoY
Corvel Financial Results
CorVel Corporation reported financial results for its second fiscal quarter ended September 30, 2026, with quarterly revenue increasing 11% year-over-year to $267 million. Diluted earnings per share rose 24% to $0.67, driven by strong momentum in workers' compensation and liability businesses and the implementation of new national health plan contracts within its CERIS division.
- Term
- Q2 2027